A Strategic Approach to
Public & Investor Relations
At HLTH Communications, we believe that clear, strategic communication is vital for building trust and fostering strong relationships. Our expert team crafts tailored public and investor relations strategies that resonate with your audience, ensuring your brand’s message is impactful and engaging. Whether you’re in biotech, neuroscience, mental health, psychedelics, or longevity, we help you navigate complex landscapes and achieve your goals through effective and thoughtful communication.
Amplify your story, ignite your success
At HLTH Communications, we specialize in transforming your unique story into powerful narratives that resonate and inspire. Our strategic approach leverages media relations, thought leadership, and innovative content strategies to amplify your brand’s presence and impact. By aligning your message with your audience’s values and interests, we help you ignite success, drive engagement, and achieve measurable business outcomes. Let us help you turn your vision into a compelling story that captivates and delivers results.
Natalie & Kristina
Our Services
Designed to meet the diverse needs of our clients
Thought Leadership
Developing and promoting expert insights positions you as a leader in your field, leveraging executive commentary, bylined articles, and speaking opportunities.
Investor Relations
Build and maintain strong investor relationships through transparent communication strategies that highlight financial performance and strategic vision.
Content Strategy & Design
Compelling content creation includes brand strategy, creative writing, immersive digital experiences, and visual storytelling that resonate with your audience.
Media Relations
Achieve targeted media coverage by aligning your messaging with trends and establishing credibility through strategic campaigns.
Social Media
Engage investor communities with data-driven social media strategies that amplify your message and enhance your online presence.
Events
Ensure high engagement and seamless delivery with flawlessly planned and executed events, from large-scale conferences to intimate exhibitions.
Areas of Focus
We've helped leading brands across industries achieve measurable growth and market leadership
Biotech
We provide strategic communications for biotech companies, ensuring their groundbreaking innovations receive the attention they deserve.
Neuropsychiatry
Our expertise in neuropsychiatric communications helps companies in this field effectively convey complex medical information.
Neuroscience
Our firm supports neuroscience companies by creating compelling narratives that explain their research and breakthroughs.
Mental Health
We specialize in promoting mental health initiatives and organizations, using strategic communications to raise awareness and reduce stigma.
Psychedelics
We help psychedelic research and therapy companies communicate their innovative approaches and scientific findings.
Longevity
Our communications expertise in the longevity sector focuses on promoting advancements in life extension and healthy aging.
The Results
The numbers speak for themselves
$6.7M
USD Raised in Q1 2024
3x
Dominance in industry conversations within 6 months
65%
Average client year-over-year growth
Client Case Studies
Learn How We Did It
Our Clients Have Been Featured In
Founders Led
Meet Our Team
Kristina Spionjak
🇬🇧 London, UK
Kristina Spionjak is a seasoned public relations professional with over 10 years of experience. She connects entrepreneurs with their ideal audiences across various industries through media relations and events. Kristina excels at managing PR campaigns and high-profile events, ensuring clients reach the right stakeholders.
Natalie Dolphin
🇨🇦 Toronto, Canada
Natalie Dolphin has over 15 years of experience in marketing, business development, and capital markets. She has a proven track record in raising capital, having secured $6.7M USD for clients in Q1 2024 alone, and excels in driving business growth and securing investment opportunites.
Mentions in the Press
Celebrating Our Clients' success
Stealth mode biotech startups: Everything you need to know
Many biotech startups decide to operate in what is known as “stealth mode”. Here, they are almost invisible to the outside world, able to look inward and avoid the distractions and tribulations that can potentially arise from being in the public eye. But what exactly is stealth mode and what benefits does it offer young […]
Read Now
Enveric Biosciences Presents Compelling Preclinical Data On Lead Compound EB-003 At 7th Neuropsychiatric Drug Summit
Enveric Biosciences ENVB recently announced that research highlighting the Company’s lead compound, EB-003, is being presented at the 7th Neuropsychiatric Drug Summit. EB-003 is a promising neuroplastogenic and non-hallucinogenic N, N-Dimethyltryptamine (DMT) analog drug candidate that elicited beneficial outcomes in preclinical models of anxiety and depression. The conference is being held at the Hilton Boston […]
Read Now
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences’ Breakthrough Research
Neuroplastogen biotech company Enveric Biosciences ENVB has presented research highlighting its lead compound, EB-003 at the 7th Neuropsychiatric Drug Summit showing beneficial outcomes in preclinical models of anxiety and depression.
Read Now
The Future Of MDMA-Assisted Therapy After FDA Rejection — Where Do We Go Now?
The recent FDA rejection of MDMA-assisted therapy for PTSD put forth by Lykos Therapeutics has left the psychedelic drug development and mental health communities at a critical juncture, reigniting discussions about the future of innovative mental health treatments. As the industry faces this significant setback, the question emerges: where do we go now?
Read Now
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
Psychedelics biotech Enveric Biosciences ENVB announced positive preclinical results of its EB-003 drug candidate to be delivered via oral administration. EB-003 is a new, neuroplastogenic molecule designed to treat serious mental health disorders without the hallucinogenic effect typically associated with DMT (N,N-Dimethyltryptamine) and other psychedelic compounds. The results indicate that oral administration of EB-003 provides […]
Read Now
Enveric Biosciences Announces Promising Preclinical Results for EB-003
Enveric Biosciences, a forward-thinking biotechnology company specializing in neuroplastogenic treatments for neuropsychiatric disorders, has announced preclinical results that underscore the potential of their novel drug candidate, EB-003. These findings, detailed in a recent press release, highlight the drug’s oral bioavailability and significant brain exposure, positioning it as a promising treatment for severe mental health conditions.
Read Now
The Business of Hlth Podcast
Listen to the latest episode of our podcast
The Business of HLTH podcast, a HLTH Communications Production, provides an in-depth look at the evolving health sector. We interview investors and innovators, exploring the latest in health tech, longevity and biotech investments, uncovering where capital is moving. Join us for insights into the future of health.
How we will work with you
Our Process
1 Research
Our initial focus will be on examining your past actions to determine what has been effective and what hasn’t. We’ll also delve into understanding your target audience, collecting essential messages and materials, and clarifying your objectives. Additionally, we’ll analyze your competitors’ marketing strategies to identify successful approaches.
2 Implementation
Following the research phase, we’ll develop and align a Media Relations program with your broader marketing strategy. This will involve setting up your press office and brainstorming pitch ideas.
3 Pitch Pitch Pitch
Through meticulous planning, organization, and interaction with journalists, we aim to secure high-quality coverage for you. This will contribute significantly to building a positive and robust media presence, which will be highly valued by your customers and search engines like Google.
4 Evaluation
You’ll have real-time access to information about our pitch efforts, ongoing conversations with targeted journalists, and all metrics related to secured coverage.
Testimonials
Hear from Happy Customers
Take Your First Steps
Are you ready to elevate your brand?
Explore how we can help you achieve your goals and drive tangible business results.